Invasive Ductal Carcinoma, Fibroadenoma (USA)

63 year old lady. With a previous corneal biopsy of a fibroadenoma and a marker inside the lesion. The patient was asymptomatic. On the inside to the images you can see the fibroadenoma and the marker and an asymmetry. In the inner quadrants of the left breast. Let's move to the tomorrow study. Here you can see the fibroadenoma, and if we analyze the asymmetry, we can see an irregular, indistinctive mass. Here it is. If we focus in the left breast. You can see that lesion and on the Thermo spot we can clearly detect this speculated irregular mouse. Highly suspicious for malinas. Finally, we performed a Tyson study showing this enhancing mass. The correlation. So to sum, there was a previous fibroadenoma and. And irregular. Indistinct mass. And the correlation with MRI, MRI showed two additional decisions that finally were false positive results after the biopsy. So the final result of the biopsy was an invasive ductal carcinoma. And the take home message is that Tyson was useful to detect and characterize the mask and the fibroadenoma did not enhance on Tyson, which is good news.

11/22/2021 Digital Breast Tomosynthesis and Contrast Enhanced Mammography Prof. Dr. Luis Pina Breast Imaging Department (Radiología mamaria) Clínica Universidad de Navarra, Pamplona / Spain SIEMENS . 08_TICEM_4, PID3648 Healthineers * 1/1/2022 F PID3648 Series Navigator INSIGHT_2D Add Study PID3648 10/1/2021 (Study date) Current Current Current Mamograffa Bilateral LCC INSIGHT 2D_RMLO INSIGHT_2D_RCC Viewing Favorite Layouts MR DYN MR.Dyna ... MR.Empty ReportFlow BASI Printing Tools Findings MR 4:42 PM US Clinical information 63-year-old female Previous core needle biopsy of Fibroadenoma (FA) that is marked with a clip in the left breast Asymptomatic RCC RMLO Slice 18/ 64 Slice 29 / 67 Slice 14 / 63 Slice 11 / 62 Slice thickness: 1.00 mm Slice thickness: 1.00 mm |Slice thickness: 1.00 mm 1 1 1 Slice 39 / 67 Slice 43 / 62 BASIC Slice 25 / 44 Slice 41 / 54 LMLO LowEnergy Recombined 1.09 cm Ultrasound: Previous Fibroadenoma Ultrasound: Invasive ductal carcinoma (IDC) LOG 1/1/2022, F Subtraction 2:26:04 PM 1976 IMA 61 ultrasound SP H7.2 SL 1.5 mm Zoom 1.71 p2 10:26 PM Biopsy SP H10.2 SP F10.8 SP F24.3 SP F37.8 INSIGHT_2D_RMLO 4:47 PM Pathology Invasive ductal carcinoma (IDC) Conclusion TiCEM correctly distinguished between the (enhancing) malignant IDC and the (non-enhancing) benign FA. Siemens Healthcare GmbH, 2022 Sometimes IN2D images (= synthetic mammograms) are shown while verbally referring to the conventional mammograms. The products/features (mentioned herein) are not commercially available in all countries. Their future availability cannot be guaranteed. Results from case studies are not predictive of results in other cases. Results in other cases may vary. The statements by Siemens' customers described herein are based on results that were achieved in the customer's unique setting. Since there is no "typical" setting and many variables exist (e.g ., hospital size, samples mix, case mix, level of IT adoption) there can be no guarantee that other customers will achieve the same results. Dr. Luis Pina is employed by an institution that receives financial support from Siemens Healthineers for collaborations. SIEMENS